11 May 2020 Comment
Cerus Endovascular has secured Conformité Européenne (CE) mark approval for its coil-assisted flow diverter Neqstent. However, GlobalData expects that the device may experience a slow uptake due to the Covid-19...
5 March 2020 News
The US Food and Drug Administration has issued a final rule to ban the use of electrical stimulation devices (ESDs) for the treatment of self-injurious or aggressive behaviour in neuroatypical...
25 February 2020 News
Avanos Medical has secured clearance from the US Food and Drug Administration (FDA) for marketing its 80-Watt COOLIEF Radiofrequency (RF) system for neurological lesion procedures.
21 February 2020 News
A non-invasive magnetic stimulation headset could improve motor function in stroke patients, a new study has found.
18 February 2020 News
US-based medical device company Cerus Endovascular has secured CE Mark approval for Contour Neurovascular System, intended to treat intracranial aneurysms.
28 January 2020 Analysis
BioXcel Therapeutics is developing an acute agitation drug, BXCL501, for Alzheimer’s disease. To improve management and prevention of agitation, the company is leveraging an existing wearable device and developing AI...
27 January 2020 News
Brain tumour therapy company GT Medical Technologies has received US Food and Drug Administration clearance for an expanded indication of its GammaTile therapy.